Clinical Trial Update: 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 5-fluorouracil followed by interferon-alfa-2b in previously treated patients with metastatic gastrointestinal cancer, metastatic renal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Gastrointestinal Cancer Metastatic, Renal Cell Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2016-07-25